.Debt to Equity since 2005
Difficulty: Beginner
Calculation
Bristol-Myers Squibb Co., debt to equity, long-term trends, calculation
| Debt to Equity | = | Total debt1 | ÷ | Total Bristol-Myers Squibb Company shareholders' equity1 | |
|---|---|---|---|---|---|
| Dec 31, 2005 | = | ÷ | |||
| Dec 31, 2006 | = | ÷ | |||
| Dec 31, 2007 | = | ÷ | |||
| Dec 31, 2008 | = | ÷ | |||
| Dec 31, 2009 | = | ÷ | |||
| Dec 31, 2010 | = | ÷ | |||
| Dec 31, 2011 | = | ÷ | |||
| Dec 31, 2012 | = | ÷ | |||
| Dec 31, 2013 | = | ÷ | |||
| Dec 31, 2014 | = | ÷ | |||
| Dec 31, 2015 | = | ÷ | |||
| Dec 31, 2016 | = | ÷ | |||
| Dec 31, 2017 | = | ÷ |
1 USD $ in millions
Source: Based on data from Bristol-Myers Squibb Co. Annual Reports
Comparison to Competitors
Bristol-Myers Squibb Co., debt to equity, long-term trends, comparison to competitors
| Bristol-Myers Squibb Co. | Abbott Laboratories | AbbVie Inc. | Allergan PLC | Amgen Inc. | Biogen Inc. | Celgene Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2005 | |||||||||||||
| Dec 31, 2006 | |||||||||||||
| Dec 31, 2007 | |||||||||||||
| Dec 31, 2008 | |||||||||||||
| Dec 31, 2009 | |||||||||||||
| Dec 31, 2010 | |||||||||||||
| Dec 31, 2011 | |||||||||||||
| Dec 31, 2012 | |||||||||||||
| Dec 31, 2013 | |||||||||||||
| Dec 31, 2014 | |||||||||||||
| Dec 31, 2015 | |||||||||||||
| Dec 31, 2016 | |||||||||||||
| Dec 31, 2017 |
Source: Based on data from Bristol-Myers Squibb Co. Annual Reports
Comparison to Pharmaceuticals & Biotechnology Sector
Bristol-Myers Squibb Co., debt to equity, long-term trends, comparison to Pharmaceuticals & Biotechnology sector
| Bristol-Myers Squibb Co. | Pharmaceuticals & Biotechnology | |
|---|---|---|
| Dec 31, 2005 | ||
| Dec 31, 2006 | ||
| Dec 31, 2007 | ||
| Dec 31, 2008 | ||
| Dec 31, 2009 | ||
| Dec 31, 2010 | ||
| Dec 31, 2011 | ||
| Dec 31, 2012 | ||
| Dec 31, 2013 | ||
| Dec 31, 2014 | ||
| Dec 31, 2015 | ||
| Dec 31, 2016 | ||
| Dec 31, 2017 |
Source: Based on data from Bristol-Myers Squibb Co. Annual Reports
Comparison to Health Care Industry
Bristol-Myers Squibb Co., debt to equity, long-term trends, comparison to Health Care industry
| Bristol-Myers Squibb Co. | Health Care | |
|---|---|---|
| Dec 31, 2005 | ||
| Dec 31, 2006 | ||
| Dec 31, 2007 | ||
| Dec 31, 2008 | ||
| Dec 31, 2009 | ||
| Dec 31, 2010 | ||
| Dec 31, 2011 | ||
| Dec 31, 2012 | ||
| Dec 31, 2013 | ||
| Dec 31, 2014 | ||
| Dec 31, 2015 | ||
| Dec 31, 2016 | ||
| Dec 31, 2017 |
Source: Based on data from Bristol-Myers Squibb Co. Annual Reports
